Engineering of implantable cartilaginous structures from bone marrow-derived mesenchymal stem cells

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Prosthetic joint replacement is a common treatment for joint defects.
• Tissue-engineered cartilaginous structures offer a potential alternative therapeutic approach.
• Biodegradable scaffolds are crucial for supporting cell growth and differentiation.

Purpose of the Study:

• To explore the use of biodegradable hydrogels combined with polyglycolic acid (PGA) scaffolds for mesenchymal stem cell (MSC) chondrogenic differentiation.
• To examine the influence of type I collagen and alginate hydrogels on extracellular matrix composition in tissue-engineered constructs.
• To assess the potential of these constructs as implantable cartilaginous structures for joint defect repair.

Main Methods:

• Mesenchymal stem cells (MSCs) were isolated from rabbits and cultured on PGA scaffolds within type I collagen or alginate hydrogels.
• Constructs were cultured in serum-free medium with transforming growth factor beta-1 under dynamic conditions in bioreactors for 3-6 weeks.
• Extracellular matrix composition, including glycosaminoglycans (GAGs) and collagen types, was analyzed.

Main Results:

• All cell-polymer constructs maintained size and shape, with increased thickness over time.
• Hyaline-like extracellular matrix with GAGs and type II collagen was developed in all groups.
• Alginate-PGA/MSCs constructs showed delayed cartilage matrix deposition but higher GAGs and lower type I collagen content at 6 weeks.

Conclusions:

• Composite hydrogel-PGA scaffolds support in vitro growth of implantable cartilaginous structures in a bioreactor system.
• The choice of scaffold material influences the timeline of chondrogenic differentiation and matrix deposition.
• These findings highlight the potential of engineered cartilage for joint defect treatment, with scaffold selection being critical for optimal outcomes.